Company page

Lexaria Bioscience Corp.

Lexaria Bioscience Corp. (Ticker: LEXX) is a public company based in the United States, with a market capitalization of approximately $13.39 million. The company focuses on developing and commercializing its proprietary drug delivery technology, which aims to enhance the bioavailability of various compounds. Lexaria is committed to advancing its innovative solutions in the bioscience sector.